Literature DB >> 9753278

Evidence for autonomic nervous system imbalance in women with irritable bowel syndrome.

M Heitkemper1, R L Burr, M Jarrett, V Hertig, M K Lustyk, E F Bond.   

Abstract

Autonomic nervous system function was assessed in women with and without irritable bowel syndrome using frequency domain measures of heart rate variability. Women were interviewed and placed into the irritable bowel syndrome (N = 25) group based on history of diagnosis and self-report of current gastrointestinal symptoms. Women in the control group denied a history of chronic gastrointestinal symptoms (N = 15). Women were followed for one menstrual cycle with a symptom diary, and during mid-luteal phase they wore a Holter 24-hr electrocardiograph monitor. Women with irritable bowel syndrome demonstrated significantly lower vagal tone as measured by the high frequency spectrum relative to control women. In addition, women with irritable bowel syndrome had a flattened 24-hr pattern of heart rate variability, with significantly lower levels of vagal tone during sleep. These results suggest that systemic sympathovagal balance may be shifted in a subset of women with irritable bowel syndrome.

Entities:  

Mesh:

Year:  1998        PMID: 9753278     DOI: 10.1023/a:1018871617483

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

Review 2.  The neurobiology of stress and gastrointestinal disease.

Authors:  E A Mayer
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

3.  A comprehensive study of autonomic dysfunction in the fibromyalgia patients.

Authors:  Poorvi Kulshreshtha; Rajiva Gupta; Raj Kumar Yadav; Ramesh Lal Bijlani; Kishore Kumar Deepak
Journal:  Clin Auton Res       Date:  2011-10-25       Impact factor: 4.435

4.  So-eum type as an independent risk factor for irritable bowel syndrome: a population-based study in Korea.

Authors:  Seung Ku Lee; Dae Wui Yoon; Hyeryeon Yi; Si Woo Lee; Jong Yeol Kim; Jin Kwan Kim; Jeong Hwa Hong; Chol Shin
Journal:  J Altern Complement Med       Date:  2014-08-22       Impact factor: 2.579

5.  Autonomic nervous system function in women with irritable bowel syndrome.

Authors:  M Heitkemper; M Jarrett; K C Cain; R Burr; R L Levy; A Feld; V Hertig
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

6.  Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome.

Authors:  M Jarrett; M Heitkemper; K C Cain; R L Burr; V Hertig
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

Review 7.  The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome.

Authors:  Lin Chang
Journal:  Gastroenterology       Date:  2011-01-19       Impact factor: 22.682

8.  Autonomic function at rest and in response to emotional and rectal stimuli in women with irritable bowel syndrome.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

9.  Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Sanna McKinzie; Irene Busciglio; Phillip A Low; Seth Sweetser; Duane Burton; Kari Baxter; Michael Ryks; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

10.  Relationships of abdominal pain, reports to visceral and temperature pain sensitivity, conditioned pain modulation, and heart rate variability in irritable bowel syndrome.

Authors:  M E Jarrett; C J Han; K C Cain; R L Burr; R J Shulman; P G Barney; B D Naliboff; J Zia; M M Heitkemper
Journal:  Neurogastroenterol Motil       Date:  2016-03-19       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.